ATLL

Clinical trials for ATLL explained in plain language.

Never miss a new study

Get alerted when new ATLL trials appear

Sign up with your email to follow new studies for ATLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New drug combo shows promise for rare blood cancer

Disease control Completed

This study tested a drug called belinostat combined with zidovudine (AZT) as a follow-up treatment for people with adult T-cell leukemia-lymphoma (ATLL), a rare and aggressive blood cancer. The goal was to see if the combination could make cancer cells disappear from the blood. T…

Matched conditions: ATLL

Phase: PHASE2 • Sponsor: University of Miami • Aim: Disease control

Last updated May 17, 2026 13:56 UTC

ATLL

Get alerted when new ATLL trials appear

New drug combo shows promise for rare blood cancer